⌘K

Login Start Free

Home/Filings/4/0001209191-17-040574

4//SEC Filing

Karyopharm Therapeutics Inc. 4

Accession 0001209191-17-040574

$KPTICIK 0001503802operating

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 4:52 PM ET

Size

5.4 KB

Accession

0001209191-17-040574

Insider Transaction Report

Form 4

Period: 2017-06-15

Karyopharm Therapeutics Inc.KPTI

Director

Transactions

Award
Nonstatutory Stock Option (right to buy)
2017-06-15+17,000→ 17,000 total
Exercise: $9.18Exp: 2027-06-14→ Common Stock (17,000 underlying)

Footnotes (1)

[F1]This option vests as to 100% of the underlying shares on June 15, 2018, provided that the holder continues to serve as a director of the issuer through such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Karyopharm Therapeutics Inc.

CIK 0001503802

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001503802

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 4:52 PM ET
Size: 5.4 KB

View on SEC.gov